May 8, 2019 – In the News
Six Epstein Becker Green Attorneys Featured in “Law360 Names Attys Who Moved Up the Firm Ranks in Q1″ Law360
April 16, 2019 – Article
State Legislatures Spring Ahead with Restrictions on Drug Copay Accumulators Managed Care
February 15, 2019 – In the News
John Linehan Quoted in “Trump’s Drug Rebate Ban Faces Fraught Legal Path” Law360
February 5, 2019 – Client Alerts
HHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs Health Care and Life Sciences Client Alert
December 5, 2018 – Client Alerts
CMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 2020 Health Care and Life Sciences Client Alert
October 25, 2018 – Article
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model Health Law Advisor Blog
October 19, 2018 – Article
New Federal Laws Banning “Gag Clauses” in the Pharmacy Health Law Advisor Blog
January 3, 2018 – Client Alerts
Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 1: Negotiated Prices for Drugs Health Care and Life Sciences Client Alert
January 3, 2018 – Client Alerts
Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 2: Beneficiary Cost, Access, and Protection Health Care and Life Sciences Client Alert
May 2017 – Video
Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series
April 7, 2017 – In the News
John Linehan Quoted in “PBM Executive Pleads Guilty in $3.5 Million Kickback Scheme” Drug Benefit News
March 24, 2017 – In the News
Epstein Becker Green’s Successful Defense of False Claims Act Case Noted in Multiple Publications Multiple Publications
January 17, 2017 – In the News
John Linehan Quoted in “Path of Uncertainty: Pharm Exec’s 2017 Industry Forecast” PharmExec.com
December 14, 2016 – Article
The Future Impact of Populism on Drug Pricing Reform Health Law Advisor
December 8, 2016 – Article
Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing Facilities Specialty Pharmacy Times
December 8, 2016 – Article
Politics, Populism, and the Future of Prescription Drug Pricing Reform PharmExec.com
March 23, 2016 – Article
Drug Compounding: Cause and Cure for High Drug Prices? PharmExec.com
February 25, 2016 – Client Alerts
CMS Proposes Modest Increases to Medicare Advantage and Part D Plan Payment Rates Accompanied by Significant Revisions to Risk Adjustment Methodologies and Employer/Union-Only Group Welfare Plan Bids Health Care and Life Sciences Client Alert
January 29, 2016 – Client Alerts
CMS Issues Final Rule on Covered Outpatient Drugs Health Care and Life Sciences Client Alert
December 14, 2015 – Client Alerts
California Imposes Controversial Cost-Sharing Restrictions to Facilitate Patient Access to Expensive Drugs Health Care and Life Sciences Client Alert
October 5, 2015 – Client Alerts
West Coast States Bolster Momentum for Pharmacist Provider Status Reforms Health Care and Life Sciences Client Alert
June 1, 2015 – Article
FDA Signals Tougher Approach to Animal Drug Compounding Law360
May 28, 2015 – Client Alerts
FDA Signals Restrictive Regulatory Approach in Draft Guidance on Animal Drug Compounding Health Care and Life Sciences Client Alert
May 7, 2015 – Client Alerts
CMS Amends Medicare Part D Program Integrity Regulations to Facilitate Beneficiary Access and Expand Coverage for Pharmacist Prescribers Health Care and Life Sciences Client Alert
April 14, 2015 – In the News
Client Alert by Hutchinson, Kocot, Linehan Mentioned in “CMS Issues 2016 Parameters for ‘Creditable’ Drug Coverage” SHRM.org
April 10, 2015 – Client Alerts
2016 Payment Notice and Final Call Letter: CMS Gives with One Hand and Takes Away with the Other Health Care and Life Sciences Client Alert
December 10, 2014 – Client Alerts
CMS Seeks Comments on Proposed Enhancements and Modifications to the Star Ratings for Medicare Advantage and Part D Prescription Drug Plans Health Care and Life Sciences Client Alert
December 4, 2014 – Client Alerts
Medicare Shared Savings Program Proposed Rule: Enough Incentive to Encourage More ACO Risk? Health Care and Life Sciences Client Alert
November 2014 – Article
The Legal Implications of Pharmacist Provider Status and the Transformation of an Industry AHLA Connections
February 3, 2014 – Article
As Preferred Pharmacy Networks Become Prominent, Legal Hurdles Remain Health Briefs E-Newsletter, Healthcare Liability and Litigation Practice Group, American Health Lawyers Association
- Page 1 of 2